翻訳と辞書 |
Alzheimer's Drug Discovery Foundation : ウィキペディア英語版 | Alzheimer's Drug Discovery Foundation
The Alzheimer's Drug Discovery Foundation (ADDF) is a nonprofit organization founded in 1998 by co-chairmen Leonard A. Lauder and Ronald S. Lauder of the Estée Lauder Companies cosmetics family and led by Dr. Howard Fillit,〔http://alzdiscovery.org/about-addf/member/howard-fillit〕 a geriatrician and neuroscientist. The ADDF provides funding to scientists who are conducting promising, innovative Alzheimer's disease drug research worldwide. ADDF funds early-stage research and early-phase clinical trials that might otherwise go unfunded. By supporting research projects around the world, it seeks to increase the chances of finding treatments for Alzheimer's disease, related dementias and cognitive aging〔(National Institute of Neurological Disorders and Stroke )〕 ADDF has invested nearly $65 million to fund some 450 Alzheimer’s drug discovery programs and clinical trials in academic centers and biotechnology companies in 18 countries.〔 The ADDF also publishes peer-reviewed scientific articles with the goal of accelerating and improving Alzheimer's disease drug discovery research.〔(Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies. Alzheimer's Research and Therapy, 2011 )〕〔(Developing novel blood-based biomarkers for Alzheimer's disease. Alzheimer's & Dementia, 2014 )〕 ==Funding Model==
The ADDF is a biomedical venture philanthropy. Many of its grants are structured as investments, providing a return that is reinvested in new drug research. After initial ADDF funding, grantees have received commitments of over $2 billion 〔http://alzdiscovery.org/about-addf/what-we-do〕 in follow-on funding from government, pharmaceutical companies and venture capital firms to further advance drug research.
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Alzheimer's Drug Discovery Foundation」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|